The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 23, 2018
Filed:
Jun. 17, 2015
Applicant:
Children's Hospital & Research Center Oakland, Oakland, CA (US);
Inventors:
Gregory R. Moe, Alameda, CA (US);
Charles Paul Plested, Walnut Creek, CA (US);
Assignee:
CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND, Oakland, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/30 (2006.01); A61K 47/48 (2006.01); A61K 31/715 (2006.01); A61K 39/395 (2006.01); A61K 39/40 (2006.01); C07K 19/00 (2006.01); A61K 39/44 (2006.01); A61K 39/00 (2006.01); A61K 39/108 (2006.01); A61K 39/095 (2006.01); C07K 16/12 (2006.01); C08B 37/00 (2006.01); C08L 5/00 (2006.01); C07K 16/28 (2006.01); A61K 47/68 (2017.01);
U.S. Cl.
CPC ...
A61K 47/48569 (2013.01); A61K 31/715 (2013.01); A61K 39/0011 (2013.01); A61K 39/0258 (2013.01); A61K 39/095 (2013.01); A61K 39/395 (2013.01); A61K 39/39558 (2013.01); A61K 39/40 (2013.01); A61K 39/44 (2013.01); A61K 47/6851 (2017.08); C07K 16/1217 (2013.01); C07K 16/28 (2013.01); C07K 16/3076 (2013.01); C07K 16/3084 (2013.01); C07K 19/00 (2013.01); C08B 37/0063 (2013.01); C08L 5/00 (2013.01); A61K 2039/6012 (2013.01); A61K 2039/6037 (2013.01); C07K 2317/14 (2013.01); C07K 2317/30 (2013.01); C07K 2317/31 (2013.01); C07K 2317/33 (2013.01); C07K 2317/40 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01); C07K 2317/73 (2013.01); C07K 2319/00 (2013.01);
Abstract
The present invention generally provides compositions methods and composition relating to the diagnosis and/or treatment of cancers having a cell surface de-N-acetylated sialic acid antigen, e.g., an at least partially de-N-acetylated ganglioside and/or a de-N-acetylated sialic acid-modified cell surface protein.